Antiviral peptides against dengue virus
Dengue virus (DENV) poses a continuous threat to the public health of the global community with over 390 million infections and 25,000 deaths annually. The efficacy of the only licensed dengue vaccine, Dengvaxia, against all four DENV serotypes is less than desirable in real-world setting. In additi...
| Main Authors: | , , |
|---|---|
| Format: | Book Section |
| Published: |
Academic Press
2022
|
| Subjects: | |
| Online Access: | http://eprints.sunway.edu.my/2160/ |